CRISPR Therapeutics AG
看多

$CRSP - a blast from the past

136
Last year, I made nice gains from this ticker.
As you can see in the chart, it has taken a beating.

It gave me false signals in March that it was rebounding.
It is, again, giving me signals but this time the signals are quite a bit more impressive. Instead of meandering its way above key levels, yesterday it made a power move through the level.
It is now on its volume shelf and it will run into its next bag holders around $155, where I assume it will take time to digest that level before again moving higher.
For now, I am moderately adding to my position with patience.
After $157 I will get more aggressive, with tight stop loss, to ride this stock to reach all time highs (above $220).

Of my three genome stocks that I hold and play, CRSP is the strongest and healthiest play that has the highest confidence.
Because I have been burned by this before, I use caution and discipline and do not enter without hitting key levels. It can just as easily reverse on you and the losses are stomach churning.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。